JP2018500287A5 - - Google Patents

Download PDF

Info

Publication number
JP2018500287A5
JP2018500287A5 JP2017523358A JP2017523358A JP2018500287A5 JP 2018500287 A5 JP2018500287 A5 JP 2018500287A5 JP 2017523358 A JP2017523358 A JP 2017523358A JP 2017523358 A JP2017523358 A JP 2017523358A JP 2018500287 A5 JP2018500287 A5 JP 2018500287A5
Authority
JP
Japan
Prior art keywords
disease
disorder
compound
pharmaceutically acceptable
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017523358A
Other languages
English (en)
Japanese (ja)
Other versions
JP6998204B2 (ja
JP2018500287A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/058193 external-priority patent/WO2016069974A1/en
Publication of JP2018500287A publication Critical patent/JP2018500287A/ja
Publication of JP2018500287A5 publication Critical patent/JP2018500287A5/ja
Application granted granted Critical
Publication of JP6998204B2 publication Critical patent/JP6998204B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017523358A 2014-10-30 2015-10-30 Rorγtのモジュレーターとしてのトリフルオロメチルアルコール Expired - Fee Related JP6998204B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462072563P 2014-10-30 2014-10-30
US62/072,563 2014-10-30
PCT/US2015/058193 WO2016069974A1 (en) 2014-10-30 2015-10-30 TRIFLUOROMETHYL ALCOHOLS AS MODULATORS OF RORyt

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2018200608A Division JP6623270B2 (ja) 2014-10-30 2018-10-25 Rorγtのモジュレーターとしてのトリフルオロメチルアルコール
JP2020104927A Division JP2020180129A (ja) 2014-10-30 2020-06-18 Rorγtのモジュレーターとしてのトリフルオロメチルアルコール

Publications (3)

Publication Number Publication Date
JP2018500287A JP2018500287A (ja) 2018-01-11
JP2018500287A5 true JP2018500287A5 (enExample) 2018-12-06
JP6998204B2 JP6998204B2 (ja) 2022-02-04

Family

ID=54754732

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2017523358A Expired - Fee Related JP6998204B2 (ja) 2014-10-30 2015-10-30 Rorγtのモジュレーターとしてのトリフルオロメチルアルコール
JP2018200608A Expired - Fee Related JP6623270B2 (ja) 2014-10-30 2018-10-25 Rorγtのモジュレーターとしてのトリフルオロメチルアルコール
JP2020104927A Withdrawn JP2020180129A (ja) 2014-10-30 2020-06-18 Rorγtのモジュレーターとしてのトリフルオロメチルアルコール

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2018200608A Expired - Fee Related JP6623270B2 (ja) 2014-10-30 2018-10-25 Rorγtのモジュレーターとしてのトリフルオロメチルアルコール
JP2020104927A Withdrawn JP2020180129A (ja) 2014-10-30 2020-06-18 Rorγtのモジュレーターとしてのトリフルオロメチルアルコール

Country Status (40)

Country Link
US (2) US9850236B2 (enExample)
EP (2) EP3354651B1 (enExample)
JP (3) JP6998204B2 (enExample)
KR (2) KR20170127580A (enExample)
CN (3) CN107827841A (enExample)
AR (2) AR102480A1 (enExample)
AU (2) AU2015339087B2 (enExample)
BR (2) BR122017023050A2 (enExample)
CA (1) CA2965512C (enExample)
CL (3) CL2017001042A1 (enExample)
CO (1) CO2017005014A2 (enExample)
CR (2) CR20170542A (enExample)
CY (1) CY1121716T1 (enExample)
DK (1) DK3212643T3 (enExample)
EA (2) EA033699B1 (enExample)
EC (1) ECSP17033054A (enExample)
ES (2) ES2858503T3 (enExample)
GT (1) GT201700090A (enExample)
HR (1) HRP20190900T1 (enExample)
HU (1) HUE043624T2 (enExample)
IL (2) IL251865A0 (enExample)
JO (2) JOP20200117A1 (enExample)
LT (1) LT3212643T (enExample)
MA (1) MA40873B1 (enExample)
ME (1) ME03426B (enExample)
MX (2) MX369567B (enExample)
PE (2) PE20180250A1 (enExample)
PH (2) PH12017500800A1 (enExample)
PL (1) PL3212643T3 (enExample)
PT (1) PT3212643T (enExample)
RS (1) RS58613B1 (enExample)
SG (2) SG10201805355YA (enExample)
SI (1) SI3212643T1 (enExample)
SM (1) SMT201900290T1 (enExample)
SV (1) SV2017005429A (enExample)
TR (1) TR201907763T4 (enExample)
TW (2) TWI667230B (enExample)
UY (2) UY36377A (enExample)
WO (1) WO2016069974A1 (enExample)
ZA (3) ZA201703679B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201803869A (zh) * 2016-04-27 2018-02-01 健生藥品公司 作為RORγT調節劑之6-胺基吡啶-3-基噻唑
US11230555B2 (en) 2018-03-12 2022-01-25 Escalier Biosciences B.V. Bicyclic RORγ modulators
EP3765020A4 (en) 2018-03-12 2021-09-22 Escalier Biosciences B.V. SPIROCYCLIC MMR-GAMMA MODULATORS
JP2021529161A (ja) 2018-06-18 2021-10-28 ヤンセン ファーマシューティカ エヌ.ベー. RORγtのモジュレーターとしてのピリジニルピラゾール
JP2021528405A (ja) 2018-06-18 2021-10-21 ヤンセン ファーマシューティカ エヌ.ベー. RORγtのモジュレータとしてのアミド置換チアゾール
CA3103770A1 (en) * 2018-06-18 2019-12-26 Janssen Pharmaceutica Nv Phenyl and pyridinyl substituted imidazoles as modulators of roryt
WO2019244001A1 (en) 2018-06-18 2019-12-26 Janssen Pharmaceutica Nv 6-aminopyridin-3-yl pyrazoles as modulators of roryt
WO2023232870A1 (en) 2022-05-31 2023-12-07 Immunic Ag Rorg/rorgt modulators for the treatment of virus infections like covid-19
WO2024089216A1 (en) 2022-10-27 2024-05-02 Syngenta Crop Protection Ag Novel sulfur-containing heteroaryl carboxamide compounds
CN119528866B (zh) * 2024-11-28 2025-10-17 河南农业大学 一种含双三氟甲基的香豆素叔醇类化合物及其制备方法和应用

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL91418A (en) 1988-09-01 1997-11-20 Rhone Poulenc Agrochimie (hetero) cyclic amide derivatives, process for their preparation and fungicidal compositions containing them
JPH10504542A (ja) 1994-07-27 1998-05-06 ジー.ディー.サール アンド カンパニー 炎症処置用の置換チアゾール化合物
HUP0303829A3 (en) 2001-04-16 2006-02-28 Tanabe Seiyaku Co Large conductance calcium-acitvated k channel opener compounds, use thereof and pharmaceutical compositions containing them
EA007933B1 (ru) 2001-08-13 2007-02-27 Янссен Фармацевтика Н.В. 2,4,5-тризамещенные производные тиазолила и их противовоспалительная активность
SA04250288B1 (ar) * 2003-09-19 2008-07-19 سولفاي فارماسوتيكالز بي . في مشتقات ثيازول thiazole كمعدلات لمستقبل المكونات الكيميائية للقنب cannabinoid
US8188128B2 (en) 2005-05-12 2012-05-29 The University Of Medicine And Dentistry Of New Jersey Opioid receptor subtype-selective agents
GB0518237D0 (en) * 2005-09-07 2005-10-19 Angeletti P Ist Richerche Bio Therapeutic compounds
WO2007087427A2 (en) 2006-01-25 2007-08-02 Synta Pharmaceuticals Corp. Thiazole and thiadiazole compounds for inflammation and immune-related uses
WO2008064318A2 (en) 2006-11-22 2008-05-29 University Of Medicine And Dentistry Of New Jersey Peripheral opioid receptor active compounds
WO2008064317A1 (en) 2006-11-22 2008-05-29 University Of Medicine And Dentistry Of New Jersey Lipophilic opioid receptor active compounds
WO2009011850A2 (en) 2007-07-16 2009-01-22 Abbott Laboratories Novel therapeutic compounds
EP2586311B1 (de) 2008-07-17 2016-12-14 Bayer CropScience AG Heterocyclische Verbindungen als Schädlingsbekämpfungsmittel
WO2010118078A1 (en) * 2009-04-08 2010-10-14 Idenix Pharmaceuticals, Inc. Macrocyclic serine protease inhibitors
AR079022A1 (es) 2009-11-02 2011-12-21 Sanofi Aventis Derivados de acido carboxilico ciclico sustituidos con acilamino, su uso como productos farmaceuticos, composicion farmaceutica y metodo de preparacion
EP2368886A1 (en) * 2010-03-01 2011-09-28 Phenex Pharmaceuticals AG Novel compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (ROR gamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune desease
EP3002008B8 (en) 2010-03-11 2018-10-24 New York University Amido compounds as roryt modulators and uses thereof
WO2011112264A1 (en) 2010-03-11 2011-09-15 New York University Compounds as rorϒt modulators and uses thereof
WO2011115892A1 (en) 2010-03-15 2011-09-22 Griffin Patrick R Modulators of the retinoic acid receptor-related orphan receptors
WO2012027965A1 (en) 2010-09-01 2012-03-08 Glaxo Group Limited Novel compounds
WO2012074547A2 (en) 2010-11-29 2012-06-07 New York University STEROID COMPOUNDS AS RORγt MODULATORS AND USES THEREOF
KR101958699B1 (ko) 2010-12-28 2019-03-15 라이온 가부시키가이샤 구강 상태의 판정 방법, 그리고 그것을 위해 사용되는 분석 용구, 장치, 및 프로그램
WO2012129491A1 (en) 2011-03-24 2012-09-27 Abbott Laboratories Trpv3 modulators
US9586928B2 (en) 2011-05-16 2017-03-07 The Scripps Research Institute Modulators of the nuclear hormone receptor ROR
EP2738170B1 (en) 2011-07-29 2017-08-30 Takeda Pharmaceutical Company Limited Heterocyclic compound
JP2014528933A (ja) 2011-09-09 2014-10-30 ニューヨーク ユニバーシティ RORγtモジュレーターとしてのアミド化合物およびその使用
GB201116641D0 (en) * 2011-09-27 2011-11-09 Glaxo Group Ltd Novel compounds
US9815851B2 (en) 2011-12-02 2017-11-14 Phenex Pharmaceuticals Ag Pyrrolo carboxamides as modulators of orphan nuclear receptor RAR-related orphan receptor-gamma (RORγ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases
US20130190356A1 (en) 2011-12-22 2013-07-25 Genentech, Inc. Benzyl sulfonamide derivatives as rorc modulators
UY34832A (es) * 2012-05-31 2013-12-31 Phenex Pharmaceuticals Ag TIAZOLES SUSTITUIDOS POR CARBOXAMIDA O SULFONAMIDA Y DERIVADOS RELACIONADOS COMO MODULADORES PARA EL RECEPTOR NUCLEAR HUÉRFANO RORy (lambda)
JO3215B1 (ar) 2012-08-09 2018-03-08 Phenex Pharmaceuticals Ag حلقات غير متجانسة بها 5 ذرات تحتوي على النيتروجين بها استبدال بكربوكساميد أو سلفوناميد كمعدلات لمستقبل نووي غير محمي RORy
WO2014062667A1 (en) * 2012-10-16 2014-04-24 Janssen Pharmaceutica Nv Phenyl linked quinolinyl modulators of ror-gamma-t
US9624210B2 (en) * 2012-12-12 2017-04-18 Merck Sharp & Dohme Corp. Amino-pyrimidine-containing spleen tyrosine kinase (Syk) inhibitors
WO2014195321A1 (en) 2013-06-04 2014-12-11 Acturum Life Science AB Triazole compounds and their use as gamma secretase modulators
CN103333168B (zh) * 2013-07-23 2015-08-05 清华大学 一种酰胺类化合物及其制备方法与应用
US9663469B2 (en) 2013-09-09 2017-05-30 Bristol-Myers Squibb Company RORγ modulators
US20150072890A1 (en) 2013-09-11 2015-03-12 20/20 Gene Systems, Inc. Methods and compositions for aiding in the detection of lung cancer
CN105555768B (zh) 2013-09-20 2018-10-16 百时美施贵宝公司 RORγ调节剂
WO2015057629A1 (en) * 2013-10-15 2015-04-23 Janssen Pharmaceutica Nv ALKYL LINKED QUINOLINYL MODULATORS OF RORyt
WO2015057206A1 (en) * 2013-10-15 2015-04-23 Janssen Pharmaceutica Nv SECONDARY ALCOHOL QUINOLINYL MODULATORS OF RORyt
US9738600B2 (en) 2013-12-05 2017-08-22 Lead Pharma Cel Models Ip B.V. ROR gamma (RORγ) modulators
CN106132931B (zh) 2014-01-06 2019-08-02 百时美施贵宝公司 碳环砜RORγ调节剂
US9637455B2 (en) 2014-01-06 2017-05-02 Bristol-Myers Squibb Company Heterocyclic sulfone RORγ modulators
ES2704460T3 (es) 2014-01-06 2019-03-18 Bristol Myers Squibb Co Moduladores de ROR gamma de ciclohexilsulfona
JP6530764B2 (ja) 2014-01-06 2019-06-12 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company RORγ調節因子としてのピロリジニルスルホン誘導体およびその使用
US11084784B2 (en) 2014-03-27 2021-08-10 Piramal Enterprises Limited ROR-gamma modulators and uses thereof
KR20170075787A (ko) 2014-10-30 2017-07-03 얀센 파마슈티카 엔.브이. RORγt의 조절제로서의 아미드 치환된 티아졸
LT3212641T (lt) 2014-10-30 2019-02-11 Janssen Pharmaceutica Nv Tiazolai, kaip roryt moduliatoriai

Similar Documents

Publication Publication Date Title
JP2018500287A5 (enExample)
JP2019515924A5 (enExample)
JP2018529650A5 (enExample)
HRP20190900T1 (hr) Trifluorometil alkoholi kao modulatori ror-gama-t
JP2015517495A5 (enExample)
JP2014503525A5 (enExample)
JP2009524691A5 (enExample)
JP2017538678A5 (enExample)
JP2016529306A5 (enExample)
JP2013523802A5 (enExample)
JP2019531279A5 (enExample)
JP2015155425A5 (enExample)
JP2019501223A5 (enExample)
JP2011511835A5 (enExample)
JP2015508823A5 (enExample)
JP2018510235A5 (enExample)
JP2016520618A5 (enExample)
JP2021500403A5 (enExample)
JP2012504133A5 (enExample)
JP2007501859A5 (enExample)
JP2020502047A5 (enExample)
JP2019516739A5 (enExample)
JP2014097964A5 (enExample)
JP2017508733A5 (enExample)
JP2020502268A5 (enExample)